OTC : CLVLF

Clinuvel Pharmaceuticals Limited — Earnings Estimates

$6.1 USD

$0 (0.0%)

Volume
1.5K
Average Volume
159
Market Capitalization
$307.51M
P/E Ratio
15.48
Dividend Yield
0.50%
Price Target
Year High
$8.60
Year Low
$6.10
Day High
—
Day Low
—
Payout Ratio
$0.08
Current Ratio
$14.64

Annual earnings financials

CLVLF financial data with annual/quarterly toggle

CLVLF GAAP EPS - Annual & Quarterly

CLVLF Sales Revenue - Annual & Quarterly

CLVLF Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

CLVLF Estimated and Actual Revenue by Quarter
CLVLF Estimated and Actual EPS by Quarter
CLVLF Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2025-12-31 1 37.41M 37.41M 37.41M 36.92M 36.92M 36.92M
2025-09-30 1 38.76M 38.76M 38.76M 38.25M 38.25M 38.25M
2025-06-30 1 61.65M 61.65M 61.65M 60.85M 60.85M 60.85M
2024-06-30 1 53.55M 53.55M 53.55M 52.86M 52.86M 52.86M
2023-12-30 1 31.14M 31.14M 31.14M 30.47M 30.47M 30.47M
CLVLF Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2025-12-31 1 12.6M 12.6M 12.6M 15.94M 15.94M 15.94M
2025-09-30 1 - - - 16.51M 16.51M 16.51M
2025-06-30 1 14.16M 14.16M 14.16M 26.26M 26.26M 26.26M
2024-06-30 1 21.96M 21.96M 21.96M 22.81M 22.81M 22.81M
2023-12-30 1 12.38M 12.38M 12.38M 14.29M 14.29M 14.29M
CLVLF Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2025-12-31 1 57.4M 57.4M 57.4M 1 0.24891 0.24891 0.24891
2025-09-30 1 59.46M 59.46M 59.46M 0 0 0 0
2025-06-30 1 94.59M 94.59M 94.59M 1 0.27976 0.27976 0.27976
2024-06-30 1 82.17M 82.17M 82.17M 1 0.4339 0.4339 0.4339
2023-12-30 1 51.47M 51.47M 51.47M 1 0.24538 0.24538 0.24538